A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Status:
Recruiting

Trial end date:
2025-09-17

Target enrollment:

Participant gender:

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Phase 2

Janssen Research & Development, LLC

Prednisone
Triamcinolone